ライフサイエンスコーパス: vital sign

1 tion by monitoring the patient condition and vital signs.

2 opinion in individual hospitals and only use vital signs.

3 cale, the Mini-Mental State Examination, and vital signs.

4 euphoria, cognitive deficits, or changes in vital signs.

5 ospital trauma patients with normal standard vital signs.

6 ion of electrocardiograms, and assessment of vital signs.

7 te +/- 11, P < .001), there was no effect on vital signs.

8 y but particularly with indirect measures of vital signs.

9 bidity and mortality, beyond the traditional vital signs.

10 Score, Injury Severity Score, and admission vital signs.

11 speeds, dyskinesia, subjective effects, and vital signs.

12 curred simultaneously with outliers in other vital signs.

13 asurements were linked to routinely measured vital signs.

14 rhage that present as severe derangements of vital signs.

15 dence of the nonrepresentativeness of hourly vital signs.

16 d with the Early Warning Score only based on vital signs.

17 392 (27.4%) patients from arrival to time of vital signs.

18 relevant changes in blood pressure or other vital signs.

19 lder age, abnormal blood tests, and abnormal vital signs.

20 adverse experiences, physical examinations, vital signs, 12-lead electrocardiogram, and laboratory s

21 ical (17%) and abnormal laboratory values or vital signs (17%).

22 ospital trauma patients with normal standard vital signs (32 LSI patients, 127 No-LSI patients).

23 dose safety assessments included orthostatic vital signs; 6-lead continuous telemetry monitoring (app

24 days later in severe distress, with unstable vital signs, a jaundiced appearance, and substantial pai

25 Other assessments included vital signs, a physical examination, and 12-lead electro

26 e studies have shown that the absence of any vital sign abnormalities or any abnormalities on chest a

27 lts, pneumonia is uncommon in the absence of vital sign abnormalities or asymmetrical lung sounds, an

28 unity-acquired pneumonia, but the absence of vital sign abnormalities substantially reduces the proba

29 Vital sign abnormalities such as fever (temperature >37.

30 incidence of adverse events or laboratory or vital sign abnormalities were observed between groups.

31 incidences of adverse events, laboratory, or vital sign abnormalities were observed between groups.

32 nitored for predefined, standardized, acute, vital-sign abnormalities or marked nursing concern.

33 tent, provided intravenous access, monitored vital signs, administered lethal injections and declared

34 se, concentrating on donor factors including vital signs after withdrawal of support.

35 cations included: oxygen desaturations <90%, vital sign alterations requiring intervention, rashes, s

36 s included oxygen desaturation <90% (n = 1), vital sign alterations requiring treatment (n = 3), rash

37 We analyzed 146 patient-years of vital sign and electrocardiography waveform time series

38 The use of temporal vital signs and a single measurement of serum biomarkers

39 Laboratory model supplemented with admission vital signs and additional laboratory data (VS model), V

40 ents, electrocardiography, and monitoring of vital signs and body weight.

41 gns monitors to assist in the acquisition of vital signs and calculation of early warning scores.

42 r side effects and gained less weight; other vital signs and cardiometabolic laboratory findings did

43 Despite changes in vital signs and catecholamine levels during sedative int

44 Vital signs and composite scores, such as the Modified E

45 During this time, vital signs and electrocardiograms were recorded at regu

46 performed similarly with regard to improving vital signs and gas exchange and avoiding intubation, th

47 y predictors of G6PD deficiency by analyzing vital signs and hematocrit and by asking screening quest

48 common operative procedures, 62% had normal vital signs and hematocrit readings before transfusion.

49 Vital signs and hematologic and biochemical parameters w

50 ng at t = 0 and were monitored over 24 h for vital signs and hemodynamics.

51 Measurement of vital signs and hormones during a 24-hr period.

52 Vital signs and laboratory results were collected before

53 clinical assessment, including the review of vital signs and laboratory tests.

54 Vital signs and laboratory values were collected to defi

55 Significant changes in vital signs and laboratory values were evaluated by usin

56 to 2014 were matched with enterprise data on vital signs and neurologic status to calculate the EWS f

57 patients may require frequent monitoring of vital signs and nursing interventions but usually do not

58 njury data, admission laboratory values, and vital signs and outcomes including mortality, tempo of t

59 n an epidemic was developed using only those vital signs and patient characteristics that were readil

60 rmal values, then correlated with changes in vital signs and pharmacologic interventions.

61 stment of ultrafiltration rates to patients' vital signs and renal function may be associated with mo

62 timeliness and low burden and therefore used vital signs and routine laboratory tests, had the greate

63 fol infusion was titrated to maintain stable vital signs and sedative levels.

64 Data on other vital signs and self-reported health measures were obtai

65 The effects of (3)He MR imaging on vital signs and Spo(2) and the relationship between pulm

66 receiver operating characteristic curve for vital signs and the Modified Early Warning Score were al

67 iver operating characteristic curves for all vital signs and the Modified Early Warning Score were hi

68 aimed to derive new centile charts for these vital signs and to compare these centiles with existing

69 ravenous hydration; systematic monitoring of vital signs and volume status; availability of key bioch

70 tibiotic treatment, liver disease, and three vital-sign and three laboratory abnormalities.

71 Clinical laboratory, electrocardiograms, vital signs, and adverse event monitoring comprised the

72 adverse events, clinical laboratory values, vital signs, and anti-AMG 334 antibodies.

73 adverse events, clinical laboratory values, vital signs, and anti-erenumab antibodies.

74 included treatment-emergent adverse events, vital signs, and change in weight.

75 kidney volume, GFR, quality of life, safety, vital signs, and clinical laboratory tests.

76 Laboratory results, vital signs, and demographics were used as predictor var

77 Demographics, vital signs, and injury severity were recorded.

78 odel, adjusting for demographics, mechanism, vital signs, and injury severity.

79 sence of organ dysfunction, abnormalities in vital signs, and major infections.

80 otypes that include laboratory data, images, vital signs, and other clinical information.

81 sion functional status, comorbid conditions, vital signs, and other physiological indices), hyperoxia

82 laboratory assessments, electrocardiograms, vital signs, and physical examination; secondary measure

83 Sepsis-induced changes in activity, vital signs, and pituitary hormones are modulated by the

84 facilities, replicated patient notes, active vital signs, and the ability to contact surgical or anes

85 , 6, and 8 hours and observed for changes in vital signs, and the concentrations of hemostatic compon

86 ales, laboratory values, electrocardiograms, vital signs, and weight change.

87 After a baseline period of 90 mins, vital signs, arterial and mixed venous blood gases, and

88 Vital signs, arterial and mixed venous blood samples, sa

89 e steady state with measurements of baseline vital signs, arterial blood gases, and ventilatory setti

90 ratory abnormalities, electrocardiogram, and vital sign assessments.

91 Data were collected on vital signs at admission to the ICU, patient characteris

92 d combat hospitals, cohorts of patients with vital signs at presentation and subsequent in-hospital d

93 stituting regular pain assessment (pain as a vital sign), audit of pain results and feedback to clini

94 Vital signs, base deficit, time from examination to oper

95 Current vital sign-based risk scores for ward patients have demo

96 ur, little is known about the differences in vital signs between elderly and nonelderly patients prio

97 d expensive to collect clinical data such as vital signs, blood culture results, key clinical finding

98 Vital signs, blood samples, electrocardiographs (ECGs),

99 Among vital signs, body temperature was best at predicting mor

100 ents at risk, particularly those with normal vital signs but ongoing, occult hypoperfusion.

101 Serial evaluations of vital signs, cardiorespiratory parameters, blood culture

102 Vital signs, catecholamine levels, and time with ischemi

103 Although age-related vital sign changes are known to occur, little is known a

104 e in blood levels of inflammatory cytokines, vital sign changes, and sickness symptoms, well-establis

105 Secondary outcomes included vital sign changes, soft-tissue anesthesia, and treatmen

106 oted no substantial changes from baseline in vital signs, clinical laboratory findings, or electrocar

107 nts, physical and neurological examinations, vital signs, clinical laboratory tests, cerebrospinal fl

108 unication are giving rise to new methods for vital sign data analysis and a new generation of transpo

109 s as real or artifacts in online noninvasive vital sign data streams to reduce alarm fatigue and miss

110 Vital sign data were abstracted from individual patient

111 synchronize exponentially growing amounts of vital sign data with electronic patient care information

112 be necessary for creating a valid archive of vital sign data within an electronic medical record.

113 We used the vital sign day as our unit of measurement, defined as al

114 We found that 15-38% of vital sign days contained at least one statistical outli

115 Approximately 30-40% of vital sign days included at least one gap of greater tha

116 imetry vital sign days, the readings in most vital sign days were normally distributed.

117 With the exception of pulse oximetry vital sign days, the readings in most vital sign days we

118 ime required to complete and record a set of vital signs decreased from 4.1+/-1.3 mins to 2.5+/-0.5 m

119 Vital sign, demographic, location, and laboratory data w

120 Among HL measures, the Newest Vital Sign demonstrated a significant relationship with

121 ly meaningful abnormalities were apparent on vital sign determinations, laboratory findings, or elect

122 Alerts were vital sign deviations beyond stability thresholds.

123 Variables studied included vital signs during the first 24 hrs of admission, Pediat

124 as well tolerated, with no marked effects on vital signs, ECG readings, or laboratory values.

125 Clinical assessment (including vital signs, echocardiograms, and electrocardiographs) a

126 ents consisted of monitoring adverse events, vital signs, electrocardiogram and laboratory results, a

127 tions included monitoring of adverse events, vital signs, electrocardiogram results, and clinical lab

128 AZD3241 included records of adverse events, vital signs, electrocardiogram, and laboratory tests.

129 No clinically significant changes in vital signs, electrocardiogram, or laboratory values wer

130 revealed no clinically meaningful changes in vital signs, electrocardiogram, or laboratory values.

131 rse events (AEs), clinical laboratory tests, vital signs, electrocardiograms, and validated scales.

132 During this time, standard vital signs, electrocardiographic (ECG) readings, and bl

133 There were no changes in vital signs, electrocardiographic findings, or laborator

134 Data on vital signs, electrolytes, arterial blood gases, and coa

135 ociated with clinically important changes in vital signs, electrolytes, arterial blood gases, or coag

136 Among multi-item measures, the Newest Vital Sign (English) performed moderately well for ident

137 , p<0.0001), and having one or more affected vital signs (fever, hypotension, tachycardia, or tachypn

138 ) for peripheral oximetry at the instant the vital sign first crossed threshold and increased to 0.87

139 ervational study of continuous monitoring of vital signs for 30 minutes after the clinical determinat

140 We aimed to compare the accuracy of vital signs for detecting cardiac arrest between elderly

141 n of calls secondary to abnormal respiratory vital signs (from 21% to 31%; difference [95% confidence

142 with adverse events, laboratory values, and vital signs graded according to the Common Terminology C

143 The EWS calculated using vital signs has been developed to identify patients at r

144 om 2008 to 2014 were merged with laboratory, vital sign, health care utilization, and postoperative c

145 In the absence of abnormalities in vital signs (heart rate > 100 beats/min, respiratory rat

146 A simple risk index based on age and vital signs (heart rate x [age/10](2)/systolic blood pre

147 Blood samples were collected, and standard vital signs (heart rate, pulse oximetry, and body temper

148 valuate a simple risk index based on age and vital signs in a community sample of patients with ST-se

149 d on the skin can be valuable for monitoring vital signs in emergency care, detecting the early onset

150 Fundamental approaches to assessing vital signs in the critically ill have changed little si

151 g optimal sampling frequencies for recording vital signs in the ICU.

152 t Commission recommended making pain the 5th vital sign, increasing the focus on postoperative pain c

153 complaint, admission diagnosis, and abnormal vital signs into bivariate and nested multivariate model

154 adverse events (AEs), physical examinations, vital signs, laboratory parameters, and electrocardiogra

155 Adverse events, vital signs, laboratory parameters, and electrocardiogra

156 No clinically significant abnormalities in vital signs, laboratory results, or electrocardiogram fi

157 e primary outcome and included assessment of vital signs, laboratory tests, and serial eye examinatio

158 ied: demographics, comorbidity, medications, vital signs, laboratory tests, severity, and symptoms.

159 Vital signs, laboratory values, and Acute Physiology and

160 of information to make decisions, including vital signs, laboratory values, and entries in the medic

161 Demographic data, vital signs, laboratory values, injury severity score, a

162 were no significant differences detected in vital signs, laboratory values, procedures, treatment, o

163 All subjects were monitored for vital signs, laboratory variables, and adverse events.

164 ere monitored for adverse events; changes in vital signs, laboratory variables, and the results of mi

165 No clinically significant vital signs, laboratory, or electrocardiogram findings w

166 There were no clinically relevant changes in vital signs, laboratory, or electrocardiogram parameters

167 Procedural monitoring included vital signs, left atrial pressure, arterial blood pressu

168 Vital signs, lipids, and laboratory parameters at 12 and

169 es, interpreted in conjunction with standard vital signs, may contribute to earlier assessments of th

170 The Mini-Cog is an ultrashort cognitive "vital signs" measure that has not been studied in patien

171 ysical examination that includes orthostatic vital signs measured in both recumbent and vertical posi

172 team calls, and decreased time required for vital signs measurement and recording (NCT01197326).

173 identified primary and secondary diagnoses, vital sign measurements, length of stay (LOS), hospital

174 t number of missing, erroneous, and outlying vital signs measurements in a large ICU database.

175 luding hand hygiene, isolation of infection, vital signs, medication delivery, and hand off.

176 ed information on demographics, comorbidity, vital signs, medications, and left ventricular systolic

177 irst appearance in the record of an abnormal vital sign meeting rapid response team criteria and the

178 Noninvasive vital sign monitoring data (heart rate, respiratory rate

179 Studies were included if they evaluated vital signs monitoring in adult human subjects.

180 Electronic automated advisory vital signs monitors may help identify such patients and

181 We deployed electronic automated advisory vital signs monitors to assist in the acquisition of vit

182 Deployment of electronic automated advisory vital signs monitors was associated with an improvement

183 deployment of electronic automated advisory vital signs monitors.

184 Vital signs more accurately detect cardiac arrest in non

185 ive airway pressure improves ventilation and vital signs more rapidly than CPAP in patients with acut

186 Loss of vital signs occurred at the scene in 48.1%, en-route in

187 or changes in clinical laboratory values or vital signs occurred during this study.

188 Vital signs of all patients were recorded before and up

189 e the progression of LO projects so that the vital signs of LO convergence can be monitored.

190 Vital signs of porcine animals were continuously monitor

191 ell tolerated, without noticeable changes in vital signs, on electrocardiograms, or in laboratory val

192 ns were recorded through day 10 and included vital signs, onset of organ dysfunction, clinical labora

193 ere obtained along with a scheduled check of vital signs or for clinical suspicion of deterioration)

194 ian not directly involved in the ordering of vital signs or laboratory data.

195 There were no differences in vital signs or laboratory safety data between the two tr

196 t gain nor clinically significant changes in vital signs or other safety parameters were observed wit

197 identified 10 studies investigating postural vital signs or the capillary refill time of healthy volu

198 dizziness (preventing measurement of upright vital signs) or a postural pulse increment of 30 beats/m

199 tients, scarring was unrelated to mortality, vital signs, or clinical symptoms but those with scarrin

200 report the effect of ibuprofen treatment on vital signs, organ failure, and mortality in hypothermic

201 ordings from a single patient for a specific vital sign over a single 24-hour period.

202 demographics, outpatient asthma medications, vital signs, oxygen saturation, and forced expiratory vo

203 Secondary outcomes included vital signs, oxygen saturation, hospitalization, physici

204 No significant changes in vital signs (P > .27) were observed, and no subjects exh

205 vs 11 [24%] of 46 patients without affected vital signs, p=0.02).

206 No significant changes in vital signs, physical examination, ECGs, or clinical lab

207 differences in markers of systemic effects (vital signs, potassium, and blood glucose concentrations

208 Patient characteristics and vital signs prior to cardiac arrest were compared betwee

209 om 2008 to 2014 were merged with laboratory, vital signs, prior healthcare utilization, and postopera

210 Vital signs, pulse oximetry, laser Doppler flowmetry, an

211 Patients in both groups had vital signs recorded after the first trigger, at 20 min

212 rns varied by less than 0.8 degrees C, their vital signs remained stable, and no complications were e

213 nically significant changes were observed in vital signs, routine laboratory values, weight, metaboli

214 significant dose-related adverse effects on vital signs, serum chemistries, ECGs, or adverse events

215 fety and toxicity were measured by comparing vital signs, serum chemistry values, or acquisition-rela

216 ncy team criteria to a database of 2,245,778 vital signs sets (103,998 admissions).

217 was time to clinical response-a composite of vital sign stabilisation and hospital discharge-in the i

218 edical devices designed for monitoring human vital signs, such as body temperature, heart rate, respi

219 Asthma control is an important "vital sign" that may be useful both for population-based

220 Safety measurements included adverse events, vital signs, the Abnormal Involuntary Movement Scale, th

221 We recorded initial vital signs, the source of infection, mortality at 28 da

222 Injection of orexin-A increased vital signs to baseline levels.

223 that adding the Early Warning Score based on vital signs to the DENWIS-indicators improves prediction

224 phasis on the status of behavior as a "sixth vital sign" to be assessed in all cancer patients throug

225 everal fields, including sensors, actuators, vital sign transducers, and energy harvesters.

226 d, for a subset of patients, high-resolution vital sign trends and waveforms.

227 noea; 96 [44%] of 217 patients with affected vital signs vs 11 [24%] of 46 patients without affected

228 e time from patient arrival to the time when vital signs were first recorded was used as a proxy for

229 Core temperature and vital signs were measured at baseline and at 5-15-minute

230 r 48 hours post-cecal ligation and puncture, vital signs were measured, and1 microL of saline with or

231 nt groups based on mean values when standard vital signs were normal.

232 alpha-chloralose anesthesia, blood gases and vital signs were normalized.

233 No clinically relevant changes in ECGs or vital signs were noted.

234 No changes in vital signs were noticed.

235 any of 21 common antipsychotic side effects, vital signs were obtained, fasting blood samples were co

236 Vital signs were recorded and serial blood samples analy

237 Vital signs were recorded over 30 min during the imaging

238 Vital signs were repeated at 25 or 49 hours post-cecal l

239 onsumption, fibrin degradation products, and vital signs were similar between the animals infused wit

240 ants on admission and every 12 h thereafter--vital signs were taken, severity of accessory muscle use

241 Changes in vital signs were tested for significance across subject

242 emographic variables, laboratory values, and vital signs were utilized in a discrete-time survival an

243 pon arrival in the emergency department, her vital signs were within normal limits, and an electrocar

244 t on admission, or who never achieved stable vital signs, were excluded from the study.

245 those during the 7 AM hour had more deranged vital signs, were more likely to have a respiratory trig

246 rolonged sedation and amnesia and stabilized vital signs while significantly decreasing diazepam and

247 rated significant, time-dependent changes in vital signs, white blood cell counts, inflammatory cytok

248 Safety assessment included measurements of vital signs with regular intervals during the imaging se

249 tology, coagulation, urinalysis, orthostatic vital signs, WSF, or 12-lead ECG parameters.